Concepedia

Berhanu Alemayehu

BA

Statistics

Publications

7

Citations

698

H-Index

7

Active since

2002

Affiliations

AstraZeneca (United States)(Current)

Thomson Reuters (United States)

Novo Nordisk (United States)

Berhanu Alemayehu is an author at AstraZeneca (United States) specializing in insulin resistance, obesity, and diabetes.

Top concepts

Publications per year

2002–2020

7

Publications

7

The Lifetime Distribution of Health Care Costs

Berhanu Alemayehu, Kenneth E. Warner · Health Services Research · 2004 · 387 citations · Full text

Cost sharing, adherence, and health outcomes in patients with diabetes.

Teresa B Gibson, Song Xue, Berhanu Alemayehu et al. · PubMed · 2010 · 141 citations

Proton Pump Inhibitor Prescribing Patterns in Newborns and Infants

Marta Illueca, Berhanu Alemayehu, Nze Shoetan et al. · The Journal of Pediatric Pharmacology and Therapeutics · 2014 · 50 citations · Full text

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes

Bijan J. Borah, Theodore Darkow, Jonathan Bouchard et al. · Clinical Therapeutics · 2009 · 39 citations

, , +13

Comparative Analysis of Two Quality-of-Life Instruments for Patients with Chronic Obstructive Pulmonary Disease

Berhanu Alemayehu, Ronald E. Aubert, Richard A. Feifer et al. · Value in Health · 2002 · 39 citations · Full text

, , +7

1–5 of 7